Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
NPJ Digital Medicine
|
August 14, 2021
Implementation of a multisite, interdisciplinary remote patient monitoring program for ambulatory management of patients with COVID-19
Jordan D Coffey, Laura A Christopherson, Amy E Glasgow, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 27, 2020
First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia
Zelalem Temesgen, Mariam Assi, Paschalis Vergidis, et al.
Gastroenterology
|
October 4, 2024
Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial
Jessica R Allegretti, Colleen R Kelly, Thomas Louie, et al.
Mayo Clinic Proceedings
|
November 6, 2020
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study
Zelalem Temesgen, Mariam Assi, F N U Shweta, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 2, 2021
Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19
Ravindra Ganesh, Colin Pawlowski, John C O'Horo, et al.
Transplantation Direct
|
January 20, 2022
Solid Organ Transplantation From SARS-CoV-2-infected Donors to Uninfected Recipients: A Single-center Experience
Channa R Jayasekera, Holenarasipur R Vikram, Zeeshan Rifat, et al.
The Journal of Clinical Investigation
|
August 19, 2021
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19
Ravindra Ganesh, Colin F Pawlowski, John C O'Horo, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
January 16, 2023
Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score
Patrick W Johnson, Katie L Kunze, Jonathon W Senefeld, et al.
Mayo Clinic Proceedings
|
May 7, 2021
A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model
Raymund R Razonable, Nicole C E Aloia, Ryan J Anderson, et al.
Mayo Clinic Proceedings
|
March 6, 2021
Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
John Charles O'Horo, James R Cerhan, Elliot J Cahn, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
NPJ Digital Medicine
|
August 14, 2021
Implementation of a multisite, interdisciplinary remote patient monitoring program for ambulatory management of patients with COVID-19
Jordan D Coffey, Laura A Christopherson, Amy E Glasgow, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 27, 2020
First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia
Zelalem Temesgen, Mariam Assi, Paschalis Vergidis, et al.
Gastroenterology
|
October 4, 2024
Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial
Jessica R Allegretti, Colleen R Kelly, Thomas Louie, et al.
Mayo Clinic Proceedings
|
November 6, 2020
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study
Zelalem Temesgen, Mariam Assi, F N U Shweta, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 2, 2021
Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19
Ravindra Ganesh, Colin Pawlowski, John C O'Horo, et al.
Transplantation Direct
|
January 20, 2022
Solid Organ Transplantation From SARS-CoV-2-infected Donors to Uninfected Recipients: A Single-center Experience
Channa R Jayasekera, Holenarasipur R Vikram, Zeeshan Rifat, et al.
The Journal of Clinical Investigation
|
August 19, 2021
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19
Ravindra Ganesh, Colin F Pawlowski, John C O'Horo, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
January 16, 2023
Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score
Patrick W Johnson, Katie L Kunze, Jonathon W Senefeld, et al.
Mayo Clinic Proceedings
|
May 7, 2021
A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model
Raymund R Razonable, Nicole C E Aloia, Ryan J Anderson, et al.
Mayo Clinic Proceedings
|
March 6, 2021
Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
John Charles O'Horo, James R Cerhan, Elliot J Cahn, et al.
Page
of 9